Iridex (IRIX) Non-Current Deffered Revenue (2018 - 2026)
Iridex's (IRIX) quarterly Non-Current Deffered Revenue came in at $6.4 million in Q2 2026, down 19.4% year-on-year from $8.0 million in Q2 2025, and down 5.57% quarter-over-quarter from $6.8 million in Q1 2026.
Iridex (IRIX) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
Iridex's Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $6.4 million for Q2 2026.
- On a quarterly basis, Non-Current Deffered Revenue fell 19.4% year-over-year to $6.4 million in Q2 2026; TTM through Apr 2026 was $6.4 million, a 19.4% decrease from a year earlier, with the FY2026 full-year figure at $6.8 million, down 18.55% from the prior year.
- Non-Current Deffered Revenue eased to $6.4 million in Q2 2026 per IRIX's latest filing, from $6.8 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $12.5 million in Q3 2022 and bottomed at $6.4 million in Q2 2026.
- The 5-year median for Non-Current Deffered Revenue is $9.9 million (2023), against an average of $9.7 million.
- Across the five-year window, Non-Current Deffered Revenue soared 3682.01% in 2022 and slipped 19.4% in 2026, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $11.7 million in 2022, then slipped by 14.62% to $10.0 million in 2023, then fell by 16.71% to $8.4 million in 2024, then slipped by 13.68% to $7.2 million in 2025, then fell by 10.9% to $6.4 million in 2026.
- Per Business Quant, the three latest IRIX Non-Current Deffered Revenue figures stand at $6.4 million (Q2 2026), $6.8 million (Q1 2026), and $7.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 6.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 6.42 Mn |
| Jan 3, 2026 | 6.80 Mn |
| Sep 27, 2025 | 7.21 Mn |
| Jun 28, 2025 | 7.59 Mn |
| Mar 29, 2025 | 7.97 Mn |
| Dec 28, 2024 | 8.35 Mn |
| Sep 28, 2024 | 8.76 Mn |
| Jun 29, 2024 | 9.26 Mn |
| Mar 30, 2024 | 9.71 Mn |
| Dec 30, 2023 | 10.03 Mn |
| Sep 30, 2023 | 10.47 Mn |
| Jul 1, 2023 | 10.88 Mn |
| Apr 1, 2023 | 11.31 Mn |
| Dec 31, 2022 | 11.74 Mn |
| Oct 1, 2022 | 12.17 Mn |
| Jul 2, 2022 | 12.54 Mn |
| Apr 2, 2022 | 12.53 Mn |
| Jan 1, 2022 | 10.93 Mn |
| Oct 2, 2021 | 10.20 Mn |
| Jul 3, 2021 | 10.48 Mn |